EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases

Hong-Wei Shi, Bo-Cheng Yang, Yun-Qing Ren iD, Yi Xue iD

Antioxidants · 18.09.2025 · 14 (9) · 1128

DOI: 10.3390/antiox14091128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 18.09.2025. Verfasst von Hong-Wei Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzho…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China under grant, the Key Research and Development Plan of Zhejiang Province, ZJU-GENSCI CHILDREN'S HEALTH RESEARCH & DEVELOPMENT CENTER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of disorders, including autoimmune, acute, and chronic inflammatory conditions, which are often characterized by immune dysregulation and excessive oxidative stress. Oxidative stress plays a pivotal role in the initiation and progression of these diseases by promoting tissue damage and sustaining inflammation. However, conventional antioxidant therapies are limited by poor bioavailability, inadequate targeting, and short-lived efficacy. In recent years, nano-antioxidants have emerged as a promising therapeutic approach due to their enhanced stability, targeted delivery capabilities, and multifunctional therapeutic effects. This review provides a comprehensive overview of recent advances in the application of nano-antioxidants in the treatment of IMIDs. Their therapeutic roles are categorized into three major groups: autoimmune diseases, acute inflammatory diseases, and chronic inflammatory diseases. In autoimmune disorders such as alopecia areata and multiple sclerosis, nano-antioxidants have demonstrated the ability to reduce oxidative damage, modulate immune responses, and alleviate clinical symptoms. In acute inflammatory conditions, including acute kidney injury and acute liver injury, these nanomaterials exert protective effects by scavenging ROS, mitigating tissue injury, and restoring organ function. In chronic inflammatory diseases such as inflammatory bowel disease and ulcerative colitis, nano-antioxidants contribute to maintaining mucosal integrity, suppressing chronic inflammation, and improving therapeutic outcomes through localized delivery and sustained release. In summary, nano-antioxidants represent a novel and promising therapeutic strategy for the management of IMIDs. Their unique physicochemical properties offer significant advantages over traditional treatments. Further research is needed to optimize their delivery platforms, evaluate long-term safety, and facilitate clinical translation.

Schlagwörter

Stichwörter der Autor:innen

alopecia areataantioxidantimmuneinflammatorymultiple sclerosis

Autor:innen und Institutionen

  • Department of Radiology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310058, China.
  • Department of Plastic Surgery, Zhongshan Hospital Affiliated to Xiamen University, School of Medicine, Xiamen University, Xiamen 361005, China.
  • Department of Dermatology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310058, China.

ORCID-Profile: Yun-Qing Ren, Yi Xue

Förderung

  • Zhejiang Provincial Natural Science Foundation of China under grant
  • the Key Research and Development Plan of Zhejiang Province
  • ZJU-GENSCI CHILDREN'S HEALTH RESEARCH & DEVELOPMENT CENTER
  • Zhejiang Provincial Natural Science Foundation of China
  • National Key R&D Program of China
  • Key Research and Development Plan of Zhejiang Province
  • ZJU-GENSCI CHILDREN’S HEALTH RESEARCH & DEVELOPMENT CENTER
  • National Key R&D Program of China

Zitieren

APA

Shi, H. W., Yang, B. C., Ren, Y. Q., & Xue, Y. (2025). Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases. Antioxidants, 14(9), 1128. https://doi.org/10.3390/antiox14091128

Vancouver

Shi HW, Yang BC, Ren YQ, Xue Y. Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases. Antioxidants. 2025;14(9):1128. doi:10.3390/antiox14091128

BibTeX
@article{Shi2025,
  author = {Shi, Hong-Wei and Yang, Bo-Cheng and Ren, Yun-Qing and Xue, Yi},
  title = {Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {1128},
  doi = {10.3390/antiox14091128}
}
Kostenlos starten →